To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.

NCT07685054 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

12700

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension
Primary Hypercholesterolemia

Sponsor

Boryung Pharmaceutical Co., Ltd